[1] Goldman S, Itshaki O, Shochat T, et al.Risk factors and outcome of polymicrobial bacteremia: a retrospective cohort study[J].Isr Med Assoc J.2020,22(5):279-284. [2] Kiani D, Quinn E L, Burch K H, et al.The increasing importance of polymicrobial bacteremia[J].JAMA.1979,242(10):1044-1047. [3] Cooper G S, Havlir D S, Shlaes D M, et al.Polymicrobial bacteremia in the late 1980s: predictors of outcome and review of the literature[J].Medicine (Baltimore),1990,69(2):114-123. [4] Zheng C, Zhang S F, Chen Q Q, et al.Clinical characteristics and risk factors of polymicrobial staphylococcus aureus bloodstream infections[J].Antimicrob Resist Infect Control,2020,9(1):76. [5] Lin J N, Lai C H, Chen Y H, et al.Characteristics and outcomes of polymicrobial bloodstream infections in the emergency department: a matched case-control study[J].Acad Emerg Med.2010,17(10):1072-1079. [6] 中华人民共和国卫生部.医院感染的诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. [7] Zhang Y Y, Du M M, Chang Y, et al.Incidence, clinical characteristics,and outcomes of nosocomial enterococcus spp. bloodstream infections in a tertiary-care hospital in Beijing,China:a four-year retrospective study[J].Antimicrob Resist Infect Control,2017,6(1):73. [8] Lay C J, Ho Y H, et al.Different clinical characteristics between polymicrobial and monomicrobial aeromonas bacteremia-a study of 216 cases[J].Inter Med,2010,49(22):2415-2421. [9] Royo-Cebrecos C, Gudiol C, Ardanuy C, et al.A fresh look at polymicrobial bloodstream infection in cancer patients[J].PLoS One,2017,12(10): 1857-1868. [10] Yo C H, Hsein Y C, Wu Y L, et al.Clinical predictors and outcome impact of community-onset polymicrobial bloodstream infection[J].Int J Antimicrob Agents,2019,54(6):716-722. [11] Sancho S, Artero A, Zaragoza R, et al.Impact of nosocomial polymicrobial bloodstream infections on the outcome in critically ill patients[J].Eur J Clin Microbiol Infect Dis.2012,31(8):1791-1796. |